Description

Tirzepatide Sodium Overview

Tirzepatide Sodium is a synthetic research peptide designed to investigate dual receptor pathways involving glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Its unique sequence and structural properties have made it a valuable tool in preclinical studies of metabolic regulation, peptide–receptor interactions, and incretin biology.

Product Details

• Form: Lyophilized (freeze-dried) powder

• Strength: Available in sterile vials (exact mg content per label)

• Amino Acid Sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS

• Note: Aib is a non-coded (non-proteinogenic) amino acid – H₂H-C(CH₃)₂-COOH

• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

• Molecular Weight: 4813.53 g/mol

• PubChem CID: 156588324

• CAS Number: 2023788-19-2

• Storage: Store in a cool, dry place; refrigerate (2–8°C) after reconstitution

Research Highlights

• Dual Agonist Mechanism: Studied for its ability to activate both GIP and GLP-1 receptors in laboratory models.

• Incretin Pathway Studies: Provides insight into glucose and lipid metabolism regulation under controlled settings.

• Peptide–Receptor Binding: Valuable for non-clinical analysis of binding, pathway activation, and metabolic signaling.

Usage and Safety Information

This compound is intended for laboratory research use only. It is not approved for human or veterinary use. Laboratory safety protocols must be followed when handling this peptide.

Important Notices

• Supplied as a lyophilized powder in a sterile, sealed vial.

• Label quantity reflects total peptide content per vial.

• Requires reconstitution (e.g., with bacteriostatic water) prior to use in laboratory experiments.

• Additional research supplies such as bacteriostatic water, syringes, and alcohol prep pads are required.

• Vial appearance, label, seal, and cap colors may vary from product photos.